Charles River Laboratories International, Inc. Common Stock (NY:CRL)

373.98 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

March 10, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Law Enforcement Supply Chain

Charles River Launches Helper Plasmid to Streamline Adeno-Associated Viral Vector Manufacturing

March 09, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Bragar Eagel & Squire, P.C. Is Investigating Fox, Norfolk Southern, Charles River, and CCSI and Encourages Investors to Contact the Firm

March 06, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

Why Charles River Stock Is Plunging Today ↗

February 22, 2023

Via Benzinga

Charles River Dives As Monkey Investigation Hamstrings 2023 Outlook ↗

February 22, 2023

The DOJ is investigating shipments of nonhuman primates from Cambodia.

Via Investor's Business Daily

This Favorable Sign Appears On Charles River's Chart ↗

January 19, 2023

Via Benzinga

ROSEN, LEADING INVESTOR COUNSEL, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

March 05, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Law Enforcement Supply Chain

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors to Inquire About Securities Class Action Investigation - CRL

March 02, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Law Enforcement Supply Chain

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors

February 27, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

$39M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying ↗

February 27, 2023

Although US stocks closed lower on Friday, there were a few notable insider trades.

Via Benzinga

ROSEN, NATIONAL TRIAL COUNSEL, Encourages Charles River Laboratories International, Inc. Investors With Losses to Inquire About Securities Class Action Investigation - CRL

February 26, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Law Enforcement Supply Chain

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Charles River Stockholders and Encourages Investors to Contact the Firm

February 24, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

Bronstein, Gewirtz & Grossman, LLC Notifies Charles River Laboratories International, Inc. (CRL) Investors of Investigation

February 24, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

CRL EQUITY ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Charles River Laboratories International, Inc. Investors With Losses In Excess of $100K to Inquire About Securities Class Action Investigation – CRL

February 23, 2023

From The Rosen Law Firm, P.A.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2023 ↗

February 23, 2023

Via Benzinga

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Charles River Laboratories International, Inc. and Encourages Investors with Losses to Contact the Firm

February 23, 2023

From The Schall Law Firm

Via Business Wire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Charles River Laboratories International, Inc. and Encourages Investors with Losses to Contact the Firm

February 22, 2023

From The Schall Law Firm

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors

February 22, 2023

From Glancy Prongay & Murray LLP

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors

February 22, 2023

From Law Offices of Howard G. Smith

Via Business Wire

The Law Offices of Frank R. Cruz Announces Investigation of Charles River Laboratories International, Inc. (CRL) on Behalf of Investors

February 22, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

Why Quoin Pharmaceuticals Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 22, 2023

Gainers Windtree Therapeutics Inc (NASDAQ: WINT) shares jumped 75.3% to $0.2921. Windtree Therapeutics has been granted U.S. patent number 11,583,540 titled "Istaroxime-Containing Intravenous...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

February 22, 2023

Via Benzinga

Charles River Laboratories Announces Fourth-Quarter and Full-Year 2022 Results and Provides 2023 Guidance

February 22, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Flagship’s Pioneering Medicines Enter Agreement Leveraging AI-Powered Logica with Aim of Creating Novel Therapies for Unmet Medical Needs

February 16, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Purespring Therapeutics Announce Gene Therapy Manufacturing Collaboration

February 15, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Launches Novel IgY-based ELISA Kit for the Detection and Quantitation of Residual Host Cell Protein

February 13, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call

February 09, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Jim Cramer Says This Stock Is Undervalued: 'I Think That It's Coming Back' ↗

February 02, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer he wants to own Sherwin-Williams Co (NYSE: SHW). "Everything that they could possibly say negative about it is out there.

Via Benzinga

Charles River Laboratories Acquires SAMDI Tech

January 30, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories, AbbVie, Star Bulk Carriers And This Big Bank Are CNBC's 'Final Trades' ↗

January 23, 2023

On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said Charles River Laboratories International, Inc. (NYSE: CRL) is trading at 20 time

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.